MALDI mass spectrometry imaging workflow for the aquatic model organisms Danio rerio and Daphnia magna

Cross-Species Extrapolation of Biological Data to Guide the Environmental Safety Assessment of Pharmaceuticals-The State of the Art and Future Priorities

The extrapolation of biological data across species is a key aspect of biomedical research and drug development. In this context, comparative biology considerations are applied with the goal of understanding human disease and guiding the development of effective and safe medicines. However, the widespread occurrence of pharmaceuticals in the environment and the need to assess the risk posed to wildlife have prompted a renewed interest in the extrapolation of pharmacological and toxicological data across the entire tree of life. To address this challenge, a biological "read-across" approach, based on the use of mammalian data to inform toxicity predictions in wildlife species, has been proposed as an effective way to streamline the environmental safety assessment of pharmaceuticals. Yet, how effective has this approach been, and are we any closer to being able to accurately predict environmental risk based on known human risk? We discuss the main theoretical and experimental advancements achieved in the last 10 years of research in this field. We propose that a better understanding of the functional conservation of drug targets across species and of the quantitative relationship between target modulation and adverse effects should be considered as future research priorities. This pharmacodynamic focus should be complemented with the application of higher-throughput experimental and computational approaches to accelerate the prediction of internal exposure dynamics. The translation of comparative (eco)toxicology research into real-world applications, however, relies on the (limited) availability of experts with the skill set needed to navigate the complexity of the problem; hence, we also call for synergistic multistakeholder efforts to support and strengthen comparative toxicology research and education at a global level. Environ Toxicol Chem 2024;43:513-525. © 2023 The Authors. Environmental Toxicology and Chemistry published by Wiley Periodicals LLC on behalf of SETAC.

[Application advances of mass spectrometry imaging technology in environmental pollutants analysis and their toxicity research]

Environmental exposures have significant impacts on human health and can contribute to the occurrence and development of diseases. Pollutants can enter the body through ingestion, inhalation, dermal absorption, or mother-to-child transmission, and can metabolize and/or accumulate in different tissues and organs. These pollutants can recognize and interact with various biomolecules, including DNA, RNA, proteins, and metabolites, disrupting biological processes and leading to adverse effects in living organisms. Thus, it is crucial to analysis the exogenous pollutants in the body, identify potential biomarkers and investigate their toxic effects. Numerous studies have shown that the metabolism rate of environmental pollutants greatly differs in various tissues and organs, their accumulation is also heterogeneous and dynamically changing. Moreover, the synthesis and accumulation of endogenous metabolites exhibit precise spatial distributions in tissues and cells. Mapping the spatial distributions of both pollutants and endogenous metabolites can discover relevant exposure biomarkers and provide a better understanding of their toxic effects and molecular mechanisms. Mass spectrometry is currently the preferred method for the qualitative and quantitative analysis of various compounds, and has been extensively utilized in pollutant and metabolomics analyses. Mass spectrometry imaging (MSI) is an emerging technology for molecular imaging that combines the information obtained by mass spectrometry with the visualization of the two- and three-dimensional spatial distributions of various molecular species in thin sample sections. Unlike other molecular imaging techniques, MSI can perform the label-free and untargeted analysis of thousands of molecules, such as elements, metabolites, lipids, peptides, proteins, pollutants, and drugs, in a single experiment with high sensitivity and throughput. Different MSI technologies, such as matrix-assisted laser desorption ionization mass spectrometry imaging, secondary ion mass spectrometry imaging, desorption electrospray ionization mass spectrometry imaging, and laser ablation inductively coupled plasma mass spectrometry imaging, have been introduced for the mapping of compounds and elements in biological, medical, and clinical research. MSI technologies have recently been utilized to characterize the spatial distribution of pollutants in the whole body and specific tissues of organisms, assess the toxic effects of pollutants at the molecular level, and identify exposure biomarkers. Such developments have brought new perspectives to investigate the toxicity of environmental pollutants. In this review, we provide an overview of the principles, characteristics, mass analyzers, and workflows of different MSI techniques and introduce their latest application advances in the analysis of environmental pollutants and their toxic effects.

Metabolomics and mass spectrometry imaging reveal the chronic toxicity of indoxacarb to adult zebrafish (Danio rerio) livers

Indoxacarb is a widely used insecticide in the prevention and control of agricultural pests, whereas its negative effects on non-target organisms remain largely unclear. Herein, we demonstrated the integrated metabolomics and mass spectrometry imaging (MSI) methods to investigate the chronic exposure toxicity of indoxacarb at environmentally relevant concentrations in adult zebrafish (Danio rerio) liver. Results showed that movement behaviors of zebrafish can be affected and catalase (CAT), glutamic oxalacetic transaminase (GOT), and glutamic pyruvic transaminase (GPT) activities were significantly increased after indoxacarb exposure for 28 days. Pathological analysis of zebrafish livers also showed that cavitation and pathological reactions occur. Metabolomics results indicated that metabolic pathways of zebrafish liver could be significantly affected by indoxacarb, such as tricarboxylic acid (TCA) cycle and various amino acid metabolisms. MSI results revealed the spatial differentiation of crucial metabolites involved in these metabolic pathways within zebrafish liver. Taken together, these integrated MSI and metabolomics results revealed that the toxicity of indoxacarb arises from metabolic pathways disturbance, which resulted in the decrease of liver detoxification ability. These findings will promote the current understanding of pesticide risks and metabolic disorders in zebrafish liver, which provide new insights into the environmental risk assessment of insecticides on aquatic organisms.